Grace Science Receives U.S. FDA Orphan Drug Designation for GS-100, an AAV9 Gene Therapy for NGLY1 Deficiency Read more
Hear from Industry Experts at the 2nd annual Wearable Injectors and Connected Devices Conference 2021 Read more
Engage with leading experts on wearable devices for remote diagnostics and patient monitoring Read more
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout Read more
Tonix Pharmaceuticals Announces Program to Develop TNX-102 SL for the Treatment of Long COVID Syndrome, also Known as Post-Acute Sequelae of COVID-19 (PASC) Read more
QIAGEN Launches Dedicated CRISPR Products for Rapid and Simplified Analysis of Gene-Editing Experiments Read more
Bioheng Biotech received Orphan Drug Designation from the U.S. FDA for the treatment of T-ALL. Read more